In vitro Anti-Alzheimer  and Anti Oxidant activity of the Peels of Citrus maxima fruits

 

P. Vijayalakshmi*, R. Radha

Department of Pharmacognosy, College of Pharmacy, Madras Medical College, Chennai – 600003

*Corresponding Author E-mail: vijayapharma7@gmail.com

 

ABSTRACT:

Alzheimer’s disease is an age-associated, irreversible, progressive neurodegenerative disease which is characterized by severe memory loss, unusual behavior, personality changes, and a decline in cognitive function. Even today Alzheimer disease  is spreading in very fast pace though large number of researchers and manufacturers are engaged to find effective medication but result is not satisfactory. Most of the drugs or medicines have high tendency of side effect. This fact made me inclined towards plants to execute the research work. Normally it is observed that side effects in plant derivative are very less. Most potential target for the treatment and slowing down of Alzheimer disease progression is cholinesterase inhibitors from plants. The anti oxidant and anti cholinesterase activity of various extracts of Citrus maxima fruit peels were studied by DPPH assay and Hydrogen Peroxide radical scavenging effect for in vitro analysis; Whereas Ellman’s colorimetric methods were used for anti cholinesterase activity estimation. Ethanolic extract shown the potent anti oxidant (DPPH; IC50= 25 µg/ml , HPSA; IC50= 54 µg/ml ) and anti cholinesterase activity with IC50 value of 115µg/ml.

These plants were found to be potent enough to be studied further for its in vivo Anti Alzheimer disease and to perform formulations.

 

KEYWORDS: Alzheimer disease, Citrus maxima, anti oxidant, anti cholinesterase activity.

 

 


INTRODUCTION:

Alzhiemer’s or Alzhiemer disease  accounts for  about 60 to 70%  of cases of dementia. It is a chronic neurodegenerative disease that usually starts slowly and gets worse over time1,2.

 

It is a peculiar disease of cerebral cortex identified by Dr. Alios Alzheimer in 1906 and was later named as Alzheimer’s disease3.  It is described as thin cortex speckled with usual brown clumps and irregular knots that was found to be growing inside the brain cells and are now known as amyloid plaques and neurofibrillary tangles.  The brains of people with AD have been found to have abundant of two abnormal structures. Amyloid plagues and neurofibrillary tangles which are made of misfolded proteins. Diagnosed in both the gender over 65 years of age4.

 

In 2006  26.6 million people of age more than 65 years was found to be affected by AD (Alzheimer’s disease).  It was predicted to affect 1 in 85 people globally by 20505. The symptoms of Alzheimer’s disease is unique for every individual6.  AD is diagnosis confirmed with behavioral assessments, cognitive tests  and followed by brain scan7. Recently researchers have found that activity-dependent neuroprotective protein (ADNP) in elderly individuals can assess the patients at risk for Alzheimer's disease. ANDP levels in blood and amyloid plaques (a hallmark Alzheimer's) in the brain," said lead researcher Illana Gozes from Tel Aviv University in Israel.

 

Several biochemical and pathological mechanism contribute to AD. These include (i). Imbalance in production of amyloid β () vs its clearance resulting in accumulation of in the form of senile plaques (Amyloid hypothesis)8. These plaques can induce neuroinflammatory process and trigger the production reactive oxygen species9. ( ii) Cholinergic deficits resulting due to enhanced activity of acetylcholinesterase and Butyl cholinesterase, contributing to the cognitive impairments seen in AD (Cholinergic hypothesis)10. Based on those hypotheses several anti amyloid11 and cholinesterase inhibitor12 are investigated for their disease modifying stratergies

 

Plant have been a major source of medicine. About 80% of the population in developing countries yet relies on plant based medicines to obtain primary health care WHO 197813.

 

Citrus maxima (Linn) of family Rutacea commonly known as Pamelo, Pomelo, Sadhaphal etc. It was traditionally used in Epilepsy, cholera, Cough, Asthma etc14. It has been evaluated for its anti diabetic15 , CNS activity16, Hypocholestremic activity17, Analgesic, anti inflammatory18, anti depressant19, anti tumor20,anti oxidant activity of leaves21 , using various parts of plant. The present study is on the in vitro anti oxidant and in vitro anti alzheimer activity of the dried peels of Citrus maxima.

 

MATERIAL AND METHODS:

Plant Material

Citrus maxima fruits were collected from Cuddalore (Tamil Nadu) in June and July 2015. The plant was authenticated for its identity by Scientist F and Head of office Dr. G.V.S. Muruthy Botanical Survey of India, Coimbatore with survey no: BSI/SR/5/23/2016/Tech/33. It was identified as Citrus maxima (Burm.) Merr. (= Aurantium maximum Burm.)-Rutaceae 

 

Preparation of samples

The Peels of fruit Citrus maxima  were shade dried, cut into pieces, powdered and was stored in the air tight container and a portion of it is used for the Pharmacognostical and Phytochemical studies and remaining it was extracted.

 

Extraction

Plant material was dried in shadow and ground to powder for extraction. The extraction was done using Soxhlet apparatus and extracted with the solvents of increasing polarity like Hexane, Ethyl acetate, ethanol and was macerated with water at the end of soxhlet extraction.

 

In Vitro Anti oxidant

In vitro antioxidant activities for the extracts were carried out using the following methods.

1. DPPH assay

2. Hydrogen peroxide scavenging assay.

 

DPPH Assay:  1, 2-Diphenyl-2-picryl hydrazyl Radical (DPPH)22

Initial volume 0.1 mL of various concentrations of samples was mixed with 0.4 mL of 0.3M DPPH reagent prepared in ethanol. The mixture was shaken thoroughly and incubated in the darkness at room temperature for 30 min. The absorbance of the reaction was measured spectrophotometrically at 517nm, immediately after mixing and then after incubation as well. The scavenging effect of DPPH free radical was calculated by using the following equation.

 

% Scavenging activity =

Abs (control) - Abs (standard) / Abs (control) × 100

 

Where control is the absorbance of the blank (a reaction with all the reagents except the test extract), and absorbance of sample is the absorbance of the test extract. Tests were carried out in triplicates to obtain 50% inhibition (IC50). Using Butylated hydroxy Toulene.

 

Hydrogen Peroxide Scavenging Assay (HPSA)23

The ability of the extracts to scavenge hydrogen peroxide was determined according to the method of Ruch. A solution of Hydrogen peroxide (2mmol/l\lt) was prepared in phosphate buffer (PH 7.4). Various concentrations of extracts (10-100µg/ml) were added to hydrogen peroxide solution (0.6ml).  Absorbance at 230nm was determined after 10min against a blank solution containing phosphate buffer without hydrogen peroxide.

 

% Scavenging activity =

Abs (control) - Abs (standard) / Abs (control) × 100

 

Compared with the ascorbic acid standard.

 

Anti-Acetylcholinesterase Assay24

The enzymatic activity was determined by Ellman’s methods developed in year 1961. It is used to measure extract for its Ache inhibition. Electric cell was considered as the enzyme source, acetyl thiocholine iodide was used as substrate and 5, 5, bis dithionitrobenzene, a dye was used for the measurement of cholinesterase activity. 

 

In this assay, 150 µl of 0.1M sodium phosphate buffer (pH 8), 10 µl of test compound solution and 20µl of enzyme solution (0.09 units/ml) were mixed and incubated at 250c for 15 min. 10 µl of the DTNB solution, 10 µl of acetyl thiocholine iodide were added to the resultant and allowed to withstand for 10 min. The intensity of the colour produced were studied using spectrophotometric observation at 410 nm. Physostigmine dissolved in ethanol is used as a standard. Percentage of enzyme inhibition was determined using the formula below

 

% Enzyme inhibition =

[(Optical density of test-blank) X 100]

Optical density of standard-blank

 

Statistical analysis:

All determinations were done for three times and results reported as mean ± Standard deviation. IC50 values were calculated and reported.

 

RESULT AND DISCUSSION:

Antioxidant activities

A number of studies shown that oxidative stress is involved in age related neurodegenerative diseases. Likewise, there are numerous studies which have examined the positive benefits of antioxidants to reduce or block neuronal death occurring in the pathophysiology of these disorder. In addition, the antioxidant potential of a compound can be attributed to its radical scavenging ability and total antioxidant activity. In order to determine the ability of the plant extracts to serve as antioxidants, two activities were measured; ability to scavenge DPPH and  Hydrogen Peroxide Scavenging assay.

 

DPPH radical scavenging activity :

Various extracts were studied for its anti oxidant activity using 1, 2-diphenyl-2-picryl hydrazyl radical (DPPH). Results are discussed in Table 1 and Fig 1.

 


 

 

 

Table 1: DPPH Radical Scavenging activity of various extract

S.No

Concentration

(µg/ml)

% Inhibition

Standard 

(Butylated hydroxyl Toulene )

Hexane

Ethyl acetate

Ethanol

Aqueous

1.

20

53.95

19.43

23.61

45.94

19.34

2.

40

64.81

29.32

31.28

59.86

29.34

3.

60

76.62

30.54

33.59

68.18

30.34

4.

80

85.21

31.34

43.16

76.95

34.32

5

100

91.45

37.34

52.23

88.87

37.45

IC50 (µg/ml)

10

152

97

25

147

 

 

 

 

Fig 1: DPPH Radical Scavenging activity of various extract

 

 

 


 

The DPPH is a stable free radical which produced deep purple colour by accepting the proton from any proton donor substance and widely used to test free radical scavenging effect. The reduction of DPPH decreases its absorbance at 517 nm due to colour change. The ethanolic extract of Citrus maxima peel showed IC50 value (µg/ml) of 25 where as Hexane, Ethyl acetate and aqueous extract showed Ic50 (µg/ml) value 152, 97, 147 respectively. Whereas the IC50 (µg/ml) value of standard BHT was 10. Ethanolic extracts of Citrus maxima peel are found to produce good scavenging activity in comparison to standard.

 

Hydrogen Peroxide Radical Scavenging Activity:

The Hexane, ethyl acetate, ethanol and aqueous extracts were subjected to hydrogen peroxide radical scavenging assay and the results are tabulated below in Table 2 and Fig 2.

 


 

 

 

Table 2: Hydrogen peroxide Radical Scavenging activity of various extract

S no

Concentration

% inhibition

Standard

(Ascorbic acid)

Hexane

Ethyl acetate

Ethanol

Aqueous

1

20 µg/ml

32.23

16.43

36.51

40.43

12.34

2

40 µg/ml

38.13

20.32

42.23

45.65

24.54

3

60 µg/ml

56.34

23.34

46.43

50.81

28.45

4

80 µg/ml

73.32

29.34

52.34

57.65

32.54

5

100 µg/ml

88.34

43.23

53.43

65.56

38.56

IC 50 (µg/ml)

47

127

77

54

131

 

                   

 

Fig 2: Hydrogen peroxide Radical Scavenging activity of various extract

 

 

 


The ability of the extract to scavenge hydrogen peroxide was determined in this method. Absorbance is measured at 230 nm and IC50 (µg/ml) value has been calculated and was found to be 54 for Ethanol, Were as Hexane, Ethyl acetate and Aqueous extract showed the IC50 –value (µg/ml) of 127,77 and 131 respectively. IC50 value of standard Ascorbic acid was 47.

 

Ethanolic extract of Citrus maxima peel was found to produce good scavenging activity in comparison to standard.

 

Anti-Acetylcholinesterase Assay

In vitro assay were performed on various extracts to select the extract for the further studies. In this assay the percentage inhibition were noticed for all the fractions. The extract with least IC50 value shows good inhibition. The result are tabulated below in Table no: 3.

 

The ethanolic extract of Citrus maxima peel shown good enzyme inhibition activity. Hence they were subjected to in vivo Pharmacological studies and result are tabulated in Table 3 and plotted in Fig 3.

 

 

 

 


Table 3: Acetyl cholinesterase assay of various extract

Extract

IC50  value

Hexane extract

215 µg/ml

Ethyl acetate extract

159 µg/ml

Ethanol extract

115 µg/ml

Aqueous extract

950µg/ml

 

 

Fig 3: Acetyl cholinesterase assay of various extract

 

 


The acetyl cholinesterase enzyme is a biomarker in amnesia. In this assay the percentage enzyme inhibition has been recorded for all the extracts. The ethanolic extract shown IC50 value of 115 µg/ml were the hexane, ethyl acetate, aqueous extract shown the IC50(µg/ml) value of 215, 159 and 950 respectively. It was observed that all the extract posses inhibitory activity against AChE, but ethanolic extract of Citrus maxima had good AChE inhibitory activity. Ethanol used as a solvent and it produced better activity as compared to aqueous is described in various reports25. The higher activity of the ethanolic extract may be due the organic solvents which are able to extract compounds with higher AChE inhibitory activity26. Thus the ethanolic extract can be used for the further studies.

 

CONCLUSION:

The study included in vitro anti oxidant and in vitro AChE inhibitory activity of the various extracts of Citrus maxima. Ethanolic extract of Citrus maxima fruit peels were found to show good radical scavenging activity in dose dependent manner. In vitro acetyl cholinesterase enzyme inhibition study by modified Ellman’s method confirms that the ethanolic extract of Citrus maxima maximum inhibition while comparing the IC50 Values of all extracts. Thus these extract have good anti oxidant potency and AchE inhibitory activity. It has thus paved a new path for an alternative anti oxidant and AChE inhibitor and futher in vivo studies could be carried out based on these reports.

 

REFERENCES:

1.     Burns A, Iliffe S (5 February 2009). "Alzheimer's disease". BMJ 338: b158.

2.     "Dementia Fact sheet N°362". World Health Organization. March 2015. Retrieved 13 January 2016.

3.     Alzheimer’s disease and Dementia. A Guide For Adult Protective Services Workers. available at http://www.dcf.state.fl.us/programs/ aps/docs/ Dementia Pamphlet. Pdf

4.     Brookmeyer R., Gray S., Kawas C. (September 1998). "Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset". American Journal of Public Health 88 (9): 1337–42.

5.     Brookmeyer, R; Johnson, E; Ziegler- Graham, K; Arrighi, HM (July 2007). "Forecasting the global burden of Alzheimer's disease". Alzheimer's and Dementia 3 (3): 186–91

6.     "What is Alzheimer's disease?". Alzheimers.org.uk. August 2007. http://www.alzheimers.org.uk/site/scripts/documents_info.php?document ID=100 Retrieved 2008-02-21.

7.     "Alzheimer's diagnosis of AD”. Alzheimer’s Research Trust. http://www.alzheimersresearch.org.uk/info/diagnosis/. Retrieved 2008-02-29.

8.     Hardy J and Selkoe D J, The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics, science, 297 (2002) 353.

9.     Vina J, Lloret A, Orti R and Alonso D, Molecular basis of the treatment of Alzhiemer’s disease with antioxidants: Prevention of oxidative stress, Mol, Aspects meds 25 (2004)117.

10.   Craig L A, Hong N S, Mc Donald R J, Revisiting the cholinergic hypothesis in the development of Alzhiemer’s disease. Neurosci behave Rev, 35 (2011) 1397.

11.   Schenk D, Basi G S, Pangalos  M N, Treatment strategies targeting Amyloid-β protein Cold spring Harb Perpect Med, 2 (2012) a006387.

12.   Mehta M, Adem A and Sabbagh M, acetyl cholinesterase inhibitors for Alzheimer’s disease, International Journal on Alzheimer’s Disease (2012) article ID 728983.

13.   Dubey NK, Rajesh Kumar, Parimila Tripathi, Global promotion of herbal medicines: India’s Opportunity, Current Science. 2004, 86 (1), 37-41.

14.   Kritikar, K.R., and Basu, B.D, Indian medicinal plants, Vol-I, International Book Distributors, 2008, 495-496.

15.   Abdul Muneer MT , Ashok Shenoy, Karunakar Hegde, Sayed Aamer and AR. Shabaraya: Evaluation of the Anti-diabetic Activity of Ethanolic Extract of Citrus maxima Stem Bark. International Journal Of Pharmaceutical And Chemical Sciences.  Jul-Sep 2014, Vol. 3 (3). 642-650.

16.   Haja Sherief Sheik, Niraimathi Vedhaiyan, Sengottuvelu Singaravel. Evaluation of Central Nervous System Activities of Citrus maxima Leaf Extract on Rodents. J App Pharm Sci, 2014; 4 (09): 077-082.

17.   Ganiyu Oboh, Fatai O. Bello, Ayokunle O. Ademosun: Hypocholesterolemic properties of grapefruit(Citrus paradisii) and shaddock (Citrus maxima) juices and inhibition of angiotensin-1-converting              enzyme activity. journal of food and drug analysis 22 (2014)477 -484.

18.   Shivananda A, Muralidhara Rao D, And Jayaveera Kn, Analgesic And Anti-Inflammatory Activities Of Citrus Maxima (J.Burm) Merr In Animal Models. Research Journal of Pharmaceutical, Biological and Chemical Sciences 2013, 4(2); 1800-1810.

19.   Vikram H Potdar, and Swati J Kibile: Evaluation of Antidepressant-like Effect of Citrus Maxima Leaves in Animal Models of Depression Iran Journal Basic Med Sci. 2011 Sep-Oct; 14(5): 478–483.

20.   Sriparna KunduSen, Malaya Gupta, Upal K. MazumderPallab K. HaldarPrerona Saha, and Asis Bala Antitumor Activity of Citrus maxima (Burm.) Merr. Leaves in Ehrlich's Ascites Carcinoma Cell-Treated Mice ISRN Pharmacology 2011.

21.   Pallab K Haldar . Sriparna Kundusen , Malaya Gupta, Upal K Mazumder , Siva P Panda and Sanjib Bhattacharya Evaluation Of In Vitro Antioxidant Activity Of Citrus Limetta And Citrus Maxima On Reactive Oxygen And Nitrogen Species Pharmacologyonline (2010), 3: 850-857 .

22.   Blois M.S. Antioxidant determination by the use of table free radical. Nature. 1958. 29: 1199-2000.

23.   Prashant R.Kaldhone., Yadunath M.joshi, Vilasrao J. Kadam and Prashanth R. Kaldhone studies on in-vitro Antioxidant activity of methanolic extract of aerial parts of Canna indica L. Journal of pharmacy research 2009,2(11): pg.no.1712-1715.

24.   Tepe B, Daferera D, Sokmen A, Sokmen M, Polissiou M. Antimicrobial and antioxidant activities of essential oil and various extracts of Salvia tomentosa Miller (Lamiaceae). Food Chem 2005; 90:333–340.

25.   Adewusi EA, Moodley N, Steenkamp V. Antioxidant and acetylcholinesterase inhibitory activity of selected southern African medicinal plants. S Afr J of Bot 2011; 3:638–644.

26.   Deepak G, Silviya S, Kishwar HK. Biochemical compositions and antibacterial activities of Lantana camara plants with yellow, lavender, red and white flowers. Eurasia J Biosci 2009; 3:69-77.

 

 

 

 

 

Received on 17.02.2016                             Modified on 05.03.2016

Accepted on 15.03.2016      ©A&V Publications All right reserved

Res. J. Pharmacology & P’dynamics. 8(1): Jan.-Mar., 2016; Page 17-22

DOI: 10.5958/2321-5836.2016.00005.7